IQV

IQVIA Holdings
NYSE

Real-time Quotes | Nasdaq Last Sale

144.99
+3.71
+2.63%
Opening 13:10 07/14 EDT
OPEN
141.13
PREV CLOSE
141.28
HIGH
145.60
LOW
140.60
VOLUME
730.15K
TURNOVER
--
52 WEEK HIGH
169.14
52 WEEK LOW
81.79
MARKET CAP
27.69B
P/E (TTM)
133.55
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 22 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average IQV stock price target is 158.28 with a high estimate of 175.00 and a low estimate of 138.00.

EPS

IQV News

More
IQVIA and AstraZeneca Team-up to Support Development of Potential COVID-19 Vaccine
IQVIA™ (NYSE:IQV) has announced its collaboration with AstraZeneca (LON: AZN) to accelerate development of a potential new vaccine for COVID-19. This joint initiative is part of the U.S. government’s recently announced Operation Warp Speed project.
Business Wire · 5h ago
IQVIA to Announce Second-Quarter Results on July 22, 2020
Business Wire · 5d ago
Were Hedge Funds Right About IQVIA Holdings, Inc. (IQV)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter
Insider Monkey · 5d ago
IQVIA Reports Strategic Alliance With LMC Manna Research
IQVIA™ (NYSE:IQV) today announced its strategic alliance with LMC Manna Research, the largest network of fully owned and integrated clinical research sites in Canada, to launch IQVIA's first Prime Site in
Benzinga · 07/02 12:03
IQVIA Collaborates with LMC Manna Research to Launch the Largest Clinical Investigation Site in Canada
IQVIA™ (NYSE: IQV) today announced its strategic alliance with LMC Manna Research, the largest network of fully owned and integrated clinical research sites in Canada, to launch IQVIA’s first Prime Site in Canada. This adds to our network of more than 980 Prim
Business Wire · 07/02 12:00
Goldilocks and the Moat Concept
GuruFocus.com · 06/23 23:14
IQVIA prices €711M debt offering
Seeking Alpha - Article · 06/11 08:02
IQVIA Inc. -- Moody's assigns Ba3 rating to IQVIA's new senior unsecured notes
Moody's Investors Service ("Moody's") assigned a Ba3 rating to the proposed senior unsecured notes of IQVIA Inc. ("IQVIA"). There are no changes to IQVIA's existing ratings, including the Ba2 Corporate Family Rating, Ba2-PD Probability of Default Rating, and
Moody's · 06/09 13:24

Industry

Biotechnology & Medical Research
+0.74%
Pharmaceuticals & Medical Research
+0.44%

Hot Stocks

Symbol
Price
%Change

About IQV

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.
More

Webull offers kinds of Iqvia Holdings Inc stock information, including NYSE:IQV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IQV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IQV stock methods without spending real money on the virtual paper trading platform.